OTCPK:MTHR.F

Stock Analysis Report

NOT FOR DISTRIBUTION
Header cover image

Executive Summary

M3, Inc. provides medical-related services primarily to physicians and other healthcare professionals through Internet. More Details

Rewards

Earnings are forecast to grow 22.98% per year

Earnings grew by 16.7% over the past year

Risk Analysis

No risks detected for MTHR.F from our risk checks.


Snowflake Analysis

Flawless balance sheet with high growth potential.

Share Price & News

How has M3's share price performed over time and what events caused price changes?


Latest Share Price and Events

Stable Share Price: MTHR.F has not had significant price volatility in the past 3 months.


Market Performance


7 Day Return

0.1%

MTHR.F

2.4%

US Healthcare Services

-0.8%

US Market


1 Year Return

n/a

MTHR.F

64.5%

US Healthcare Services

13.8%

US Market

Return vs Industry: Insufficient data to determine how MTHR.F performed against the US Healthcare Services industry.

Return vs Market: Insufficient data to determine how MTHR.F performed against the US Market.


Shareholder returns

MTHR.FIndustryMarket
7 Day0.1%2.4%-0.8%
30 Day4.5%-0.7%-5.0%
90 Dayn/a16.1%10.1%
1 Yearn/a65.0%64.5%16.4%13.8%
3 Yearn/a101.5%100.0%36.9%27.8%
5 Year210.9%210.9%164.7%161.9%85.0%64.2%

Price Volatility Vs. Market

How volatile is M3's share price compared to the market and industry in the last 5 years?


Simply Wall St News

No news available

Valuation

Is M3 undervalued compared to its fair value and its price relative to the market?

189.01x

Price to Earnings (PE) ratio


Share Price vs. Fair Value

Below Fair Value: MTHR.F ($60.28) is trading above our estimate of fair value ($14.2)

Significantly Below Fair Value: MTHR.F is trading above our estimate of fair value.


Price To Earnings Ratio

PE vs Industry: MTHR.F is poor value based on its PE Ratio (189x) compared to the US Healthcare Services industry average (63.7x).

PE vs Market: MTHR.F is poor value based on its PE Ratio (189x) compared to the US market (17.6x).


Price to Earnings Growth Ratio

PEG Ratio: MTHR.F is poor value based on its PEG Ratio (8.2x)


Price to Book Ratio

PB vs Industry: MTHR.F is overvalued based on its PB Ratio (26.3x) compared to the US Healthcare Services industry average (5.2x).


Next Steps

Future Growth

How is M3 forecast to perform in the next 1 to 3 years based on estimates from 13 analysts?

23.0%

Forecasted annual earnings growth


Earnings and Revenue Growth Forecasts


Analyst Future Growth Forecasts

Earnings vs Savings Rate: MTHR.F's forecast earnings growth (23% per year) is above the savings rate (2.2%).

Earnings vs Market: MTHR.F's earnings (23% per year) are forecast to grow faster than the US market (22.9% per year).

High Growth Earnings: earnings are expected to grow significantly over the next 3 years.

Revenue vs Market: MTHR.F's revenue (16.8% per year) is forecast to grow faster than the US market (9.9% per year).

High Growth Revenue: MTHR.F's revenue (16.8% per year) is forecast to grow slower than 20% per year.


Earnings per Share Growth Forecasts


Future Return on Equity

Future ROE: MTHR.F's Return on Equity is forecast to be high in 3 years time (20%)


Next Steps

Past Performance

How has M3 performed over the past 5 years?

14.2%

Historical annual earnings growth


Earnings and Revenue History

Quality Earnings: MTHR.F has high quality earnings.

Growing Profit Margin: MTHR.F's current net profit margins (17.1%) are higher than last year (17%).


Past Earnings Growth Analysis

Earnings Trend: MTHR.F's earnings have grown by 14.2% per year over the past 5 years.

Accelerating Growth: MTHR.F's earnings growth over the past year (16.7%) exceeds its 5-year average (14.2% per year).

Earnings vs Industry: MTHR.F earnings growth over the past year (16.7%) exceeded the Healthcare Services industry -4.8%.


Return on Equity

High ROE: MTHR.F's Return on Equity (15%) is considered low.


Next Steps

Financial Health

How is M3's financial position?


Financial Position Analysis

Short Term Liabilities: MTHR.F's short term assets (¥116.6B) exceed its short term liabilities (¥34.8B).

Long Term Liabilities: MTHR.F's short term assets (¥116.6B) exceed its long term liabilities (¥13.6B).


Debt to Equity History and Analysis

Debt Level: MTHR.F is debt free.

Reducing Debt: MTHR.F had no debt 5 years ago.

Debt Coverage: MTHR.F has no debt, therefore it does not need to be covered by operating cash flow.

Interest Coverage: MTHR.F has no debt, therefore coverage of interest payments is not a concern.


Balance Sheet


Next Steps

Dividend

What is M3 current dividend yield, its reliability and sustainability?

0.13%

Current Dividend Yield


Dividend Yield vs Market

Notable Dividend: MTHR.F's dividend (0.13%) isn’t notable compared to the bottom 25% of dividend payers in the US market (1.72%).

High Dividend: MTHR.F's dividend (0.13%) is low compared to the top 25% of dividend payers in the US market (4.94%).


Stability and Growth of Payments

Stable Dividend: MTHR.F is not paying a notable dividend for the US market, therefore no need to check if payments are stable.

Growing Dividend: MTHR.F is not paying a notable dividend for the US market, therefore no need to check if payments are increasing.


Current Payout to Shareholders

Dividend Coverage: MTHR.F is not paying a notable dividend for the US market.


Future Payout to Shareholders

Future Dividend Coverage: No need to calculate the sustainability of MTHR.F's dividend in 3 years as they are not forecast to pay a notable one for the US market.


Next Steps

Management

How experienced are the management team and are they aligned to shareholders interests?

4.3yrs

Average board tenure


CEO

Itaru Tanimura (55 yo)

20yrs

Tenure

Mr. Itaru Tanimura has been the President of M3, Inc. since September 2000. Mr. Tanimura was Partner/Joint Manager of McKinsey & Co. since December 1999. He Joined McKinsey & Co. in April 1987. He has been ...


Board Members

NamePositionTenureCompensationOwnership
Itaru Tanimura
President & Representative Director20yrsno data2.86%
¥ 1.2b
Akihiko Tomaru
Director8.25yrsno data0.065%
¥ 26.8m
Kenichiro Yoshida
External Director20yrsno datano data
Akinori Urae
Director6.25yrsno data0.10%
¥ 42.8m
Eiji Tsuchiya
Director4.25yrsno data0.0038%
¥ 1.6m
Kazuyuki Izumiya
Director2.17yrsno data0.0016%
¥ 672.3k
Kenichi Mori
Director1.67yrsno datano data
Masako Ii
Independent Director1.67yrsno datano data
Mayuka Yamazaki
Director1.67yrsno datano data

4.3yrs

Average Tenure

56yo

Average Age

Experienced Board: MTHR.F's board of directors are considered experienced (4.3 years average tenure).


Ownership

Who are the major shareholders and have insiders been buying or selling?


Insider Trading Volume

Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.


Ownership Breakdown

Dilution of Shares: Shareholders have not been meaningfully diluted in the past year.


Top Shareholders

Company Information

M3, Inc.'s company bio, employee growth, exchange listings and data sources


Key Information

  • Name: M3, Inc.
  • Ticker: MTHR.F
  • Exchange: OTCPK
  • Founded: 2000
  • Industry: Health Care Technology
  • Sector: Healthcare
  • Market Cap: JP¥4.384t
  • Listing Market Cap: JP¥41.502b
  • Shares outstanding: 678.64m
  • Website: https://corporate.m3.com

Number of Employees


Location

  • M3, Inc.
  • Akasaka Intercity
  • 10th Floor
  • Tokyo
  • 107-0052
  • Japan

Listings

TickerExchangePrimary SecuritySecurity TypeCountryCurrencyListed on
MTHR.FOTCPK (Pink Sheets LLC)YesCommon StockUSUSDSep 2004
2413TSE (The Tokyo Stock Exchange)YesCommon StockJPJPYSep 2004
2413 NBMV (Bolsa Mexicana de Valores)YesCommon StockMXMXNSep 2004
MTHR.YOTCPK (Pink Sheets LLC)UNSPON ADRUSUSDMar 2020

Biography

M3, Inc. provides medical-related services primarily to physicians and other healthcare professionals through Internet. The company operates m3.com, a members-only Web site for providing information to the ...


Company Analysis and Financial Data Status

All financial data provided by Standard & Poor's Capital IQ.
DataLast Updated (UTC time)
Company Analysis2020/09/27 06:20
End of Day Share Price2020/09/24 00:00
Earnings2020/06/30
Annual Earnings2020/03/31


Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.